Monitoring depression is very important. Often people come in for treatment when they are starting to get worse.

This study, when it is all finally published, will give us a very good idea of how to treat treatment-resistant depression, and what the next step is after the serotonin reuptake inhibitor fails.

This study, when it is all finally published, will give us a very good idea of how to treat treatment-resistant depression, and what the next step is after the SSRI fails.

Depression is devastating, and there is no shame in getting treatment.

Unfortunately, the spectrum of treatment options for depression in pregnant women is narrow, and other medicines, such as benzodiazepines, carry a Category D pregnancy risk factor with a significant confirmed risk to human fetuses.

People should be closely monitored, but not because these drugs are especially risky. The real problem in the treatment of depression is that people start medicine and the medicine has side effects or the medicine doesn't work right away, and they get discouraged and they drop out.